US Stock Market Closed

Dashboard

DexCom, Inc. (DXCM)

Current

- (-)

After Hours

Rating & Fair Value

Fair Value Premium lock
Institutional Holdings

H

Financial Strength

H

Sustainable Growth

S

Industry Comparison

H

Management & Equity

B

Analyst Opinion

S

Leverage & Liquidity

B

Fundamental Variables

H

Rating Performance

FV Performance

*There is a current rating on the stock that is included in these numbers based on its performance so far

About

DexCom, Inc. is a medical device manufacturing company. The firm engages in the design, development and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G4 PLATINUM System, DexCom G5 Mobil, DexCom Share and Mobile apps. The company was founded by John F. Burd on May 1, 1999 and is headquartered in San Diego, CA.

CEO

Kevin Ronald Sayer

Employees

5,200

Industry

Clinical Diagnostics Devices

Sector

Healthcare

Headquarters

San Diego

Exchange

NASDAQ

Summary Stats

Market Cap

7.38B

Revenue

2.57B

Net Income

212M

EPS

$2.07

Price-to-Earnings

36.33

Price-to-Book

3.37

Debt-to-Equity

1.31

News

Analyst Ratings

Price targets projected by 18 analysts

High

$540.00

Average

$462.94

Low

$350.00

Ratings calculated by 21 analysts

Buy

16

Hold

3

Sell

2

Last Dividend

Amount

-

Dividend Date

-

Frequency

-

Dividend Yield

Earnings

Most Recent Earnings

Last Earnings for Q1 2022

Last Earnings

Missed by -$0.05

Actual

$0.08 -38.5%

Consensus

0.13

Report Date

Year Ago

0.33

Year Ago Change %

Down 75%

Actual vs Estimates

XX

xxx

Upcoming Estimates Unavailable

Expected EPS
-

-

Actual EPS
-

--

Competitors

star Favorites